| 1 | 2794752 | Qinghaosu-mediated oxidation in normal and abnormal erythrocytes. | J Lab Clin Med | 1989 Oct |
1 |
| 2 | 7709742 | 3D-QSAR study on ether and ester analogs of artemisinin with comparative molecular field analysis. | Zhongguo Yao Li Xue Bao | 1994 Nov |
1 |
| 3 | 8080446 | Enhancement of hemin-induced membrane damage by artemisinin. | Biochem Pharmacol | 1994 Aug 17 |
2 |
| 4 | 9134741 | Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. | J Nat Prod | 1997 Apr |
1 |
| 5 | 9357485 | The pharmacokinetics of a single dose of artemisinin in subjects with liver cirrhosis. Bach Mai-Amsterdam Research Group on Artemisinin. | Trop Med Int Health | 1997 Oct |
1 |
| 6 | 9373657 | Severe and complicated malaria treated with artemisinin, artesunate or artemether in Viet Nam. | Trans R Soc Trop Med Hyg | 1997 Jul-Aug |
1 |
| 7 | 9604124 | Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses. | Biopharm Drug Dispos | 1998 May |
1 |
| 8 | 9728896 | Artemisinin induces omeprazole metabolism in human beings. | Clin Pharmacol Ther | 1998 Aug |
4 |
| 9 | 9929507 | High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. | Drug Metab Dispos | 1999 Feb |
1 |
| 10 | 10543871 | Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. | J Med Chem | 1999 Oct 21 |
1 |
| 11 | 10583023 | Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. | Br J Clin Pharmacol | 1999 Oct |
21 |
| 12 | 10626755 | Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19. | Fundam Clin Pharmacol | 1999 |
6 |
| 13 | 11124226 | Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. | Drug Metab Dispos | 2001 Jan |
1 |
| 14 | 11324528 | [The inhibitory effects of artemisinin-derivatives on Na+ and K+ channels in comparison with those of procaine]. | Sheng Li Xue Bao | 1998 Apr |
2 |
| 15 | 11432537 | Pharmacokinetic interactions of antimalarial agents. | Clin Pharmacokinet | 2001 |
3 |
| 16 | 11575956 | Synthesis of new artemisinin analogues from artemisinic acid modified at C-3 and C-13 and their antimalarial activity. | J Nat Prod | 2001 Sep |
2 |
| 17 | 11697139 | Proposed reductive metabolism of artemisinin by glutathione transferases in vitro. | Free Radic Res | 2001 Oct |
12 |
| 18 | 11855985 | Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues. | J Med Chem | 2002 Feb 28 |
1 |
| 19 | 11888669 | Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells. | Cancer Lett | 2002 May 28 |
1 |
| 20 | 12536531 | [Inflammatory-inducing effect of lumbar disc tissue: an experimental study]. | Hunan Yi Ke Da Xue Xue Bao | 2001 Dec 28 |
1 |
| 21 | 12619052 | Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling. | Biopharm Drug Dispos | 2003 Mar |
2 |
| 22 | 12643911 | Alkylation of manganese(II) tetraphenylporphyrin by antimalarial fluorinated artemisinin derivatives. | Bioorg Med Chem Lett | 2003 Mar 24 |
1 |
| 23 | 12844133 | Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. | Clin Pharmacol Ther | 2003 Jul |
6 |
| 24 | 13679021 | Turning an 'Achilles' Heel' into an asset--activation of HIF-1alpha during angiostatic therapy will increase tumor sensitivity to iron-catalyzed oxidative damage. | Med Hypotheses | 2003 Oct |
2 |
| 25 | 14615418 | The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies. | Lab Invest | 2003 Nov |
5 |
| 26 | 14660006 | Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. | Eur J Pharmacol | 2003 Dec 15 |
6 |
| 27 | 14698358 | Postsynaptic dopamine (D(2))-mediated behavioural effects of high acute doses of artemisinin in rodents. | Brain Res Bull | 2003 Dec 30 |
3 |
| 28 | 15115411 | Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate. | J Med Chem | 2004 May 6 |
3 |
| 29 | 15336316 | Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. | Free Radic Biol Med | 2004 Oct 1 |
1 |
| 30 | 15642597 | Effects of artemisinin-tagged holotransferrin on cancer cells. | Life Sci | 2005 Jan 28 |
4 |
| 31 | 15761118 | Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. | Mol Pharmacol | 2005 Jun |
18 |
| 32 | 15782383 | C10-modified artemisinin derivatives: efficient heme-alkylating agents. | Angew Chem Int Ed Engl | 2005 Mar 29 |
1 |
| 33 | 15878303 | Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. | Drug Resist Updat | 2005 Feb-Apr |
1 |
| 34 | 16019941 | Radiolytically induced one-electron reduction of artemisinin in H2O/ethanol (1:1 v/v) solution: a pulse radiolysis study. | Int J Radiat Biol | 2005 Apr |
1 |
| 35 | 16170412 | Yeast model uncovers dual roles of mitochondria in action of artemisinin. | PLoS Genet | 2005 Sep |
12 |
| 36 | 16185154 | Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. | Expert Opin Ther Targets | 2005 Oct |
7 |
| 37 | 16261361 | Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans. | Eur J Clin Pharmacol | 2005 Nov |
5 |
| 38 | 16412643 | The reaction of artemisinins with hemoglobin: a unified picture. | Bioorg Med Chem | 2006 May 1 |
1 |
| 39 | 16491843 | Homology modeling and molecular docking study of translationally controlled tumor protein and artemisinin. | Arch Pharm Res | 2006 Jan |
1 |
| 40 | 16506047 | Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea. | Eur J Clin Pharmacol | 2006 Apr |
2 |
| 41 | 16512009 | [The OMS demands an immediate end to the commercialization of antimalarials only consisting of artemisinine]. | Rev Med Suisse | 2006 Feb 1 |
1 |
| 42 | 16730793 | Study of the interaction of artemisinin with bovine serum albumin. | Int J Biol Macromol | 2006 Nov 15 |
2 |
| 43 | 16879742 | From chloroquine to artemisinin-based combination therapy: the Sudanese experience. | Malar J | 2006 Jul 31 |
1 |
| 44 | 16919048 | In vivo and mechanistic evidence of nuclear receptor CAR induction by artemisinin. | Eur J Clin Invest | 2006 Sep |
12 |
| 45 | 17115150 | Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. | Eur J Clin Pharmacol | 2007 Jan |
1 |
| 46 | 17279482 | Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids. | Rapid Commun Mass Spectrom | 2007 |
1 |
| 47 | 17314215 | Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. | Rheumatology (Oxford) | 2007 Jun |
1 |
| 48 | 17521300 | Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. | Fundam Clin Pharmacol | 2007 Jun |
8 |
| 49 | 18044948 | Theoretical study of radical and neutral intermediates of artemisinin decomposition. | J Chem Inf Model | 2008 Jan |
1 |
| 50 | 18223457 | Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa. | Ther Drug Monit | 2008 Feb |
1 |